Newsroom
Enveric Biosciences News
Media & Insights
Enveric Biosciences Launches Development Collaboration and Supply Agreement with PureForm Global to Support Cannabinoid Clinical Programs
February 25, 2021
Enveric Biosciences Inc. Announces Closing of $12.8 Million Registered Direct Offering of Common Stock
February 12, 2021
Enveric Biosciences Inc. Announces $12.8 Million Registered Direct Offering
February 09, 2021
Enveric Biosciences Issues Shareholder Letter Providing Strategic Vision for Advancing Novel Prescription Supportive Care Cancer Therapies
January 19, 2021
Enveric Biosciences Inc. Announces Closing of $10 Million Registered Direct Offering
January 15, 2021
Enveric Biosciences Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
January 12, 2021
Enveric Biosciences Appoints Dr. Marcus Schabacker to Board of Directors
January 05, 2021
Ameri Holdings Completes Spin-Off and Tender Offer, Changes Name to Enveric Biosciences and Begins Trading on the Nasdaq Under the Symbol "ENVB"
December 31, 2020
AMERI Holdings Announces 1-for-4 Reverse Stock Split
December 30, 2020
Jay Pharma Announces IRB Approval for Testing Proprietary CBD Formulation in Glioblastoma Multiforme (GBM)
June 02, 2020
February 25, 2021
Enveric Biosciences Inc. Announces Closing of $12.8 Million Registered Direct Offering of Common Stock
February 12, 2021
Enveric Biosciences Inc. Announces $12.8 Million Registered Direct Offering
February 09, 2021
Enveric Biosciences Issues Shareholder Letter Providing Strategic Vision for Advancing Novel Prescription Supportive Care Cancer Therapies
January 19, 2021
Enveric Biosciences Inc. Announces Closing of $10 Million Registered Direct Offering
January 15, 2021
Enveric Biosciences Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
January 12, 2021
Enveric Biosciences Appoints Dr. Marcus Schabacker to Board of Directors
January 05, 2021
Ameri Holdings Completes Spin-Off and Tender Offer, Changes Name to Enveric Biosciences and Begins Trading on the Nasdaq Under the Symbol "ENVB"
December 31, 2020
AMERI Holdings Announces 1-for-4 Reverse Stock Split
December 30, 2020
Jay Pharma Announces IRB Approval for Testing Proprietary CBD Formulation in Glioblastoma Multiforme (GBM)
June 02, 2020
